Domainex announces opening of new Biology Centre of Excellence in Cambridge, UK

Domainex has announced that it has opened a new Biology Centre of Excellence at the Unity Campus at Pampisford, Cambridge, UK, in order to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and academic institutions.
The facility had a grand opening on 7 February 2024, officiated by Mrs Julie Spence OBE CStJ QPM, HM Lord-Lieutenant of Cambridgeshire and attended by approximately 50 guests comprising senior biotech executives and local dignitaries.
The new facility covers three storeys and 24,000 ft 2 , and houses a new state-of-the-art hub for life sciences innovation, marking a more than three-fold increase on the company’s previous footprint. It is intended that this will allow for continued, rapid expansion of people and equipment to provide innovative and customised drug discovery services.
The facility will employ over 100 scientists, including biochemists, biophysicists, cell biologists, protein scientists, bioanalysts and structural biologists.
Commenting on the opening of the facility, Mrs Julie Spence stated: "It was my pleasure to open Domainex’s new Biology Centre of Excellence and to present the King’s Award for Enterprise to Domainex’s CEO, Dr Tom Mander. The King’s Awards are the most prestigious awards available to UK businesses, and are highly competitive and only awarded to the best. I would like to congratulate Domainex on this fantastic achievement and on the opening of their new facility, which will allow them to expand the high-quality, innovative drug discovery services for which they are globally renowned.”
Dr Tom Mander, chief executive officer of Domainex, added: “We are deeply honoured to receive the prestigious King’s Award from HM Lord-Lieutenant of Cambridgeshire, and are privileged that the Lord-Lieutenant has also opened our new building. Our exciting new facility will enable us to continue to expand the range of our services and will help bring much-needed treatments to patients faster and more effectively.”
Dr Trevor Askwith, head of Biology at Domainex, stated: “The whole team is delighted with the new facility and space to expand our biology and bioanalytical capabilities. We are continually investing in cutting-edge technologies and developing new services. We launched a new cryo-EM service last year and recently expanded our suite of biophysical instrumentation by adding spectral shift technology, a third, multichannel Grating Coupled Interferometry WAVEdelta system and a PEAQ-ITC instrument. The additional space will allow for further expansion and innovation.”